This volume reviews the latest research on using genetically engineered plants and plant viruses to produce new products for medicine and industry. Individual...
Lire la suite
51,22 €
Expédié sous 6 à 12 jours
Livré chez vous entre le 17 mai et le 22 mai
En magasin
Résumé
This volume reviews the latest research on using genetically engineered plants and plant viruses to produce new products for medicine and industry. Individual chapters cover the three main technologies for engineering plants : Agrobacterium-mediated transformation ; particle bombardment transformation ; and plant viral vectors. Additional chapters review strategies for producing medically important products such as vaccines, human enzymes, monoclonal antibodies, and other therapeutic proteins in plants. In addition to presenting up to date reviews of current research efforts, this book also contains some thoughtful discussions on the potential benefits and risks involved in producing pharmaceuticals in plants and the challenges of bringing such products to market.
Sommaire
Overview : the many uses and applications of transgenic plants
Lessons in gene transfer to plants by a gifted microbe
Particle bombardment mediated transformation
Plant viral vectors based on tobamoviruses
Transgenic plants for therapeutic proteins : linking upstream and downstream strategies
Feasibility of antibody production in plants for human therapeutic use
Pokeweed antiviral protein and its applications
Transgenic plants as edible vaccines cowpea mosaic virus-based vaccines.